Judit Kocsis

Years Active: 2018-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Abdallah Flaifel, Jean-Christophe Pignon, Miriam Ficial, Osvaldo Arén Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R Harrison, Philippe Barthélémy, Scott S Tykodi, Judit Kocsis, Alain Ravaud, Jeronimo R Rodriguez-Cid, Sumanta K Pal, Andre M Murad, Yuko Ishii, Shruti Shally Saggi, M Brent McHenry, Brian I Rini
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)
Ho Yeong Lim, Philippe Merle, Karl Heinz Weiss, Thomas Yau, Paul Ross, Vincenzo Mazzaferro, Jean-Frédéric Blanc, Yuk Ting Ma, Chia Jui Yen, Judit Kocsis, Su Pin Choo, Wattana Sukeepaisarnjaroen, René Gérolami, Jean-François Dufour, Edward J Gane, Baek-Yeol Ryoo, Markus Peck-Radosavljevic, Thong Dao, Winnie Yeo, Wisut Lamlertthon, Satawat Thongsawat, Michael Teufel, Katrin Roth, Diego Reis, Barrett H Childs, Heiko Krissel, Josep M Llovet
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (19) (2018)

Judit Kocsis.css-eqlu8i{font-size:small;padding-left:4px;}